119 related articles for article (PubMed ID: 10960517)
1. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
[TBL] [Abstract][Full Text] [Related]
2. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus in blood samples from volunteer donors.
Zhang HY; Kuramoto IK; Mamish D; Sazama K; Holland PV; Zeldis JB
J Clin Microbiol; 1993 Mar; 31(3):606-9. PubMed ID: 8384627
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of supplemental hepatitis C virus antibody test systems.
Evans CS; Tobler L; Polito A; Stewart J; Chien D; Wilber J; Quan S; Delaney S; Kuo G; Busch MP
Transfusion; 1992 Jun; 32(5):408-14. PubMed ID: 1320780
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
[TBL] [Abstract][Full Text] [Related]
7. Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera.
Krajden M; Zhao J; Bourke C; Scalia V; Gill P; Lau W
J Clin Microbiol; 1996 Sep; 34(9):2191-5. PubMed ID: 8862583
[TBL] [Abstract][Full Text] [Related]
8. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
9. Non-specific and specific anti-HCV results correlated to age, sex, transaminase, rhesus blood group and follow-up in blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Arch Virol; 1997; 142(3):473-89. PubMed ID: 9349294
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
11. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
Kiely P; Kay D; Parker S; Piscitelli L
Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
[TBL] [Abstract][Full Text] [Related]
12. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis C virus in autologous blood donors.
Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
[TBL] [Abstract][Full Text] [Related]
14. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
[TBL] [Abstract][Full Text] [Related]
15. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus.
Abdel-Hamid M; El-Daly M; El-Kafrawy S; Mikhail N; Strickland GT; Fix AD
J Clin Microbiol; 2002 May; 40(5):1656-9. PubMed ID: 11980937
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
[TBL] [Abstract][Full Text] [Related]
17. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Tobler LH; Stramer SL; Lee SR; Masecar BL; Peterson JE; Davis EA; Andrews WE; Brodsky JP; Kleinman SH; Phelps BH; Busch MP
Transfusion; 2003 Oct; 43(10):1452-9. PubMed ID: 14507279
[TBL] [Abstract][Full Text] [Related]
18. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
[TBL] [Abstract][Full Text] [Related]
19. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
[TBL] [Abstract][Full Text] [Related]
20. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
